Frequent loss of the BLID gene in early-onset breast cancer

Cytogenetic and Genome Research

Volumn 135, Issue 1, 2011, Pages 19-24

  Cavalli, L R ^a   Noone, A M ^a   Makambi, K H ^a   Rone, J D ^a   Kasid, U N ^a   Haddad, B R ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

BLID gene; Early onset breast cancer; Loss of heterozygosity

Indexed keywords

BH3 PROTEIN; BLID PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; ALLELES; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CHROMOSOME MAPPING; CYTOGENETICS; DNA PRIMERS; DNA PROBES; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; PROGNOSIS; SOFTWARE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 80052722267     PISSN: 14248581     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000330265     Document Type: Article

References (38)

1. Agrup M, Stal O, Olsen K, Wingren S: C-erbB-2 overexpression and survival in early onset breast cancer. Breast Cancer Res Treat 63: 23-29 (2000).
2. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, et al: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26: 3324-3330 (2008a).
3. Anders CK, Acharya CR, Hsu DS, Broadwater G, Garman K, et al: Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS One 3:e1373 (2008b).
4. Broustas C, Gokhale P, Rahman A, Dritschilo A, Ahmad I, Kasid U: BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner. J Biol Chem 279: 26780-26788 (2004). (Pubitemid 38798836)
5. Broustas CB, Ross JS, Yang Q, Sheehan CE, Riggins R, et al: The proapoptotic molecule BLID interacts with Bcl-X L and its downregulation in breast cancer correlates with poor disease-free and overall survival. Clin Cancer Res 16: 2939-2948 (2010).
6. Buckley PG, Alcock L, Bryan K, Bray I, Schulte JH, et al: Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma. Clin Cancer Res 16: 2971-2978 (2010).
7. Cavalli LR, Santos SC, Broustas CG, Rone JD, Kasid UN, Haddad BR: Assignment of BLID gene to 11q24.1 by FISH. Cancer Genet Cytogenet 186: 120-121 (2008).
8. Choi DH, Shin DB, Lee MH, Lee DW, Dhandapani D, et al: A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer 98: 1587-1595 (2003). (Pubitemid 37238613)
9. Chunder N, Mandal S, Roy A, Roychoudhury S, Panda CK: Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: Association with CYCLIN D1 amplification and survival. Diagn Mol Pathol 13: 172-182 (2004). (Pubitemid 39121744)
10. Chung M, Chang HR, Bland KI, Wanebo HJ: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77: 97-103 (1996). (Pubitemid 26002742)
11. Climent J, Dimitrow P, Fridlyand J, Palacios J, Seiebert R, et al: Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Res 67: 818-826 (2007). (Pubitemid 46192223)
12. di Iasio MG, Calin G, Tibiletti MG, Vorechovsky I, Benediktsson KP, et al: Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene 18: 1635-1638 (1999). (Pubitemid 29108064)
13. Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, et al: Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience. BMC Cancer 7: 222 (2007).
14. Ferti-Passantonopoulou A, Panani AD, Raptis S: Preferential involvement of 11q23-24 and 11p15 in breast cancer. Cancer Genet Cytogenet 51: 183-188 (1991).
15. Fischer M, Bauer T, Oberth A, Hero B, Theissen J, et al: Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q. Oncogene 29: 865-875 (2010).
16. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H: Breast cancer in young women: Poor survival despite intensive treatment. PLoS One 4:e7695 (2009).
17. Gabra H, Watson JE, Taylor KJ, Mackay J, Leonard RC, et al: Definition and refinement of a region of loss of heterozygosity at 11q23.3- q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950-954 (1996). (Pubitemid 26065383)
18. Gentile M, Olsen K, Dufmats M, Wingren S: Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: Association with poor survival. Br J Cancer 80: 843-849 (1999). (Pubitemid 29209849)
19. Gentile M, Wiman A, Thorstenson S, Loman N, Borg A, Wingren S: Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer. Int J Cancer 92: 208-213 (2001a). (Pubitemid 32225371)
20. Gentile M, Ahnstr̂ M, Scĥ F, Wingren S: Candidate tumour suppressor genes at 11q23-q24 in breast cancer: Evidence of alterations in PIG8 , a gene involved in p53-induced apoptosis. Oncogene 20: 7753-7760 (2001b). (Pubitemid 33121948)
21. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA: Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early - stage disease. J Am Coll Surg 208: 341-347 (2009).
22. Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, et al: Loss of heterozygosity at chromosome 11 in breast cancer: Association of prognostic factors with genetic alterations. Br J Cancer 72: 696-701 (1995).
23. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070 (2005). (Pubitemid 41161233)
24. Ji L, Minna JD, Roth JA: 3p21.3 tumor suppressor cluster: Prospects for translational applications. Future Oncol 1: 79-92 (2005).
25. Jong YJ, Li LH, Tsou MH, Chen YJ, Cheng SH, et al: Chromosomal comparative genomic hybridization abnormalities in early- and lateonset human breast cancers: Correlation with disease progression and TP53 mutations. Cancer Genet Cytogenet 148: 55-65 (2004). (Pubitemid 38018881)
26. Martin ES, Cesari R, Pentimalli F, Yoder K, Fishel R, et al: The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci USA 100: 11517-11522 (2003). (Pubitemid 37205968)
27. Ng WL, Yan D, Zhang X, Mo YY, Wang Y: Overexpression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair (Amst) 9: 1170- 1175 (2010).
28. Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, et al: Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 46: 761-775 (2007). (Pubitemid 46912347)
29. Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R: Association between hsa-mir- 146a genotype and tumor age-of-onset in BRCA1/BRCA2 -negative familial breast and ovarian cancer patients. Carcinogenesis 31: 2124-2126 (2010).
30. Rothenberg SM, Settleman J: Discovering tumor suppressor genes through genome-wide copy number analysis. Curr Genomics 11: 297-310 (2010).
31. Sariego J: Breast cancer in the young patient. Am Surg 76: 1397-1400 (2010).
32. Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK: Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: Clinical and prognostic significance. Cancer Sci 99: 1984-1991 (2008).
33. Song F, Zheng H, Liu B, Wei S, Dai H, et al: An miR-502-binding site single-nucleotide polymorphism in the 3α-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res 15: 6292-6300 (2009).
34. Spitz R, Hero B, Simon T, Berthold F: Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma. Clin Cancer Res 12: 3368-3373 (2006).
35. Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, et al: A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 30: 59-64 (2009).
36. Wang ZC, Lin M, Wei LJ, Li C, Miron A, et al: Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 64: 64-71 (2004). (Pubitemid 38114083)
37. Watanabe N, Nakadate H, Haruta M, Sugawara W, Sasaki F, et al: Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor. Genes Chromosomes Cancer 45: 592-601 (2006). (Pubitemid 43727166)
38. Weber-Mangal S, Sinn HP, Popp S, Klaes R, Emig R, et al: Breast cancer in young women ( ! or = 35 years): Genomic aberrations detected by comparative genomic hybridization. Int J Cancer 107: 583-592 (2003). (Pubitemid 37296119)